Skip to main content

Table 2 Outcomes of patients with MRSA pneumonia and patients with non-MRSA pneumonia after 1:4 matching

From: In-hospital mortality associated with community-acquired pneumonia due to methicillin-resistant Staphylococcus aureus: a matched-pair cohort study

  MRSA pneumonia Non-MRSA pneumonia p-value
In-hospital mortality 967 (31.2) 1429 (11.6)  < 0.001
30-day mortality 382 (12.3) 1011 (8.20)  < 0.001
90-day mortality 809 (26.1) 1330 (10.8)  < 0.001
Length of stay (days) 35.0 [22–62] 14.0 [9–23]  < 0.001
Antibiotic therapy (days) 24.0 [15–45] 9.0 [6–13]  < 0.001
Hospitalisation costs (USD) 12,156 [7827–20,615] 4665 [3163–7298]  < 0.001
  1. Data are expressed as numbers (%) or as medians [interquartile ranges]
  2. MRSA, methicillin-resistant Staphylococcus aureus; USD, United States Dollar